Should we look for giant cell arteritis in typical polymyalgia rheumatica?
Should we actively look for giant cell arteritis (GCA) in a patient with typical polymyalgia rheumatica (PMR)?
Should we actively look for giant cell arteritis (GCA) in a patient with typical polymyalgia rheumatica (PMR)?
Is ultrasonography powerful enough to replace biopsy in the diagnosis of giant cell arteritis (GCA)?
What essential changes have been introduced in the treatment of gout in recent years?
How to manage difficult-to-treat patients after a failure of allopurinol and febuxostat therapies? Is there any place for immunosuppressive agents such as methotrexate?
Which kidney comorbidities are an indication to use a uric acid–lowering treatment in gout?
Is the identification of crystals still a gold standard in diagnosing gout or can it be replaced by other modalities (ultrasonography, CT)?
Which foods actually increase/reduce the frequency of attacks in chronic gout?
When to discontinue glucocorticoids in patients with giant cell arteritis (GCA)? How to monitor the disease activity?
In what situations should we perform further investigations in patients with sacral pain? Which patients with sacral pain should have imaging studies performed? How to choose among or what are the indications for radiography, CT, and MRI of the spine, respectively?
When should we urgently qualify a patient with back pain syndrome for surgery?